Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
analgesic, andour, antipyretic, Arshak, Big, Blue, Book, bore, carryforward, cessation, CFDA, CNY, compulsory, Davtyan, deadline, decreasein, destroy, dominant, drew, faster, fierce, formulation, great, Guowei, keynote, McKinsey, negotiated, oncology, post, proceeding, propriety, prudent, reevaluation, run, Sang, settlement, speech, speed, sterilization, style, surpassed, Taiwan, treatmentof, true, turnover, vaild, voluntarily, welfare
Removed:
accumulative, ahead, airway, Appendix, brain, claudication, closer, commence, concurrently, contingency, convulsion, declined, dedicated, dried, driven, duodenal, embolism, epidemic, evolve, exercised, favorably, feature, FirsTrust, focusing, fungi, gastric, grown, Hydrochloride, hyperkalemia, IMS, intensify, intermission, intrinsic, Ischemic, isolated, knowhow, media, migration, nasal, Nasopharynx, Nominating, Peripheral, perspective, poor, Preliminary, preventive, progressing, recurrent, relief, renal, Renaud, representing, SFDA, sleep, spirit, technologically, therapy, traumatic, unit, vessel, weighted
Filing tables
Filing exhibits
CPHI similar filings
Filing view
External links
Re: Service about being independent director, Chairman of the Nominating and Compensation Committee, and member of the Audit Committee of China Pharma Holdings, Inc.
December 19, 2013
Dear Mr. Yingwen Zhang,
On behalf of the Board of Directions and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc. as an independent director, Chairman of the Nominating and Compensation Committee, and member of the Audit Committee. I look forward to working with you. Your starting date will be the date of the board approves your engagement and your engagement for this term will end on the date of the next annual shareholders meeting.
Your compensation will consist of the following:
1) A retainer of RMB 40,000 per year, payable quarterly within 5 days of the end of the quarter;
If you agree to the terms and conditions stated above, please sign and date this letter below.
I look forward to working with you and sincerely hope that your service will be enjoyable and rewarding.
Sincerely
Chairman of the Board
China Pharma Holdings, Inc.
Response:
This letter correctly sets forth the understanding of Mr. Yingwen Zhang.
By: /s/ Yingwen Zhang
Yingwen Zhang
Date: 12/19/13